Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Incomplete or no aortotomy with use of device on unaltered tissue or incomplete aortotomy when device is used on altered tissue (e.G. cardioplegia hole or aortotomy incision) could lead to an embolic event.